These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 17073696)

  • 1. Using silico methods predicting ligands for orphan GPCRs.
    Jiang Z; Zhou Y
    Curr Protein Pept Sci; 2006 Oct; 7(5):459-64. PubMed ID: 17073696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modeling and Deorphanization of Orphan GPCRs.
    Diaz C; Angelloz-Nicoud P; Pihan E
    Methods Mol Biol; 2018; 1705():413-429. PubMed ID: 29188576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Virtual screen for ligands of orphan G protein-coupled receptors.
    Bock JR; Gough DA
    J Chem Inf Model; 2005; 45(5):1402-14. PubMed ID: 16180917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ligand screening system using fusion proteins of G protein-coupled receptors with G protein alpha subunits.
    Suga H; Haga T
    Neurochem Int; 2007; 51(2-4):140-64. PubMed ID: 17659814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioinformatics-based discovery and identification of new biologically active peptides for GPCR deorphanization.
    Colette J; Avé E; Grenier-Boley B; Coquel AS; Lesellier K; Puget K
    J Pept Sci; 2007 Sep; 13(9):568-74. PubMed ID: 17694568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure versus function-The impact of computational methods on the discovery of specific GPCR-ligands.
    Bermudez M; Wolber G
    Bioorg Med Chem; 2015 Jul; 23(14):3907-12. PubMed ID: 25828056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural insights into ligand recognition and selectivity for classes A, B, and C GPCRs.
    Lee SM; Booe JM; Pioszak AA
    Eur J Pharmacol; 2015 Sep; 763(Pt B):196-205. PubMed ID: 25981303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How Ligands Illuminate GPCR Molecular Pharmacology.
    Wacker D; Stevens RC; Roth BL
    Cell; 2017 Jul; 170(3):414-427. PubMed ID: 28753422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do orphan G-protein-coupled receptors have ligand-independent functions? New insights from receptor heterodimers.
    Levoye A; Dam J; Ayoub MA; Guillaume JL; Jockers R
    EMBO Rep; 2006 Nov; 7(11):1094-8. PubMed ID: 17077864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery and validation of novel peptide agonists for G-protein-coupled receptors.
    Shemesh R; Toporik A; Levine Z; Hecht I; Rotman G; Wool A; Dahary D; Gofer E; Kliger Y; Soffer MA; Rosenberg A; Eshel D; Cohen Y
    J Biol Chem; 2008 Dec; 283(50):34643-9. PubMed ID: 18854305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The identification of ligands at orphan G-protein coupled receptors.
    Wise A; Jupe SC; Rees S
    Annu Rev Pharmacol Toxicol; 2004; 44():43-66. PubMed ID: 14744238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative and systems pharmacology 2. In silico polypharmacology of G protein-coupled receptor ligands via network-based approaches.
    Wu Z; Lu W; Yu W; Wang T; Li W; Liu G; Zhang H; Pang X; Huang J; Liu M; Cheng F; Tang Y
    Pharmacol Res; 2018 Mar; 129():400-413. PubMed ID: 29133212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An ultra-HTS process for the identification of small molecule modulators of orphan G-protein-coupled receptors.
    Cacace A; Banks M; Spicer T; Civoli F; Watson J
    Drug Discov Today; 2003 Sep; 8(17):785-92. PubMed ID: 12946641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emerging concepts of guanine nucleotide-binding protein-coupled receptor (GPCR) function and implications for high throughput screening.
    Eglen RM; Bosse R; Reisine T
    Assay Drug Dev Technol; 2007 Jun; 5(3):425-51. PubMed ID: 17638542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-Throughput Screening for Allosteric Modulators of GPCRs.
    Bertekap RL; Burford NT; Li Z; Alt A
    Methods Mol Biol; 2015; 1335():223-40. PubMed ID: 26260604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In silico identification of new ligands for GPR17: a promising therapeutic target for neurodegenerative diseases.
    Eberini I; Daniele S; Parravicini C; Sensi C; Trincavelli ML; Martini C; Abbracchio MP
    J Comput Aided Mol Des; 2011 Aug; 25(8):743-52. PubMed ID: 21744154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Virtual Screening of Human Class-A GPCRs Using Ligand Profiles Built on Multiple Ligand-Receptor Interactions.
    Chan WKB; Zhang Y
    J Mol Biol; 2020 Aug; 432(17):4872-4890. PubMed ID: 32652079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Computational approaches for ligand discovery and design in class-A G protein- coupled receptors.
    Rodríguez D; Gutiérrez-de-Terán H
    Curr Pharm Des; 2013; 19(12):2216-36. PubMed ID: 23016842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mass-spectrometry-based method for screening of new peptide ligands for G-protein-coupled receptors.
    Cologna CT; Gilles N; Echterbille J; Degueldre M; Servent D; de Pauw E; Quinton L
    Anal Bioanal Chem; 2015 Jul; 407(18):5299-307. PubMed ID: 25935673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. WDL-RF: predicting bioactivities of ligand molecules acting with G protein-coupled receptors by combining weighted deep learning and random forest.
    Wu J; Zhang Q; Wu W; Pang T; Hu H; Chan WKB; Ke X; Zhang Y
    Bioinformatics; 2018 Jul; 34(13):2271-2282. PubMed ID: 29432522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.